Operating Income (Loss) in USD of BIO-RAD LABORATORIES, INC. from Q1 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Bio Rad Laboratories, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q1 2010 to Q3 2025.
  • Bio Rad Laboratories, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was $65.3M, a 1.24% increase year-over-year.
  • Bio Rad Laboratories, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was $225M, a 26.6% decline year-over-year.
  • Bio Rad Laboratories, Inc. annual Operating Income (Loss) for 2024 was $269M, a 20.4% decline from 2023.
  • Bio Rad Laboratories, Inc. annual Operating Income (Loss) for 2023 was $338M, a 30% decline from 2022.
  • Bio Rad Laboratories, Inc. annual Operating Income (Loss) for 2022 was $483M, a 3.55% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

BIO-RAD LABORATORIES, INC. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $225M $65.3M +$800K +1.24% 01 Jul 2025 30 Sep 2025 10-Q 29 Oct 2025
Q2 2025 $224M $77.1M -$24.4M -24% 01 Apr 2025 30 Jun 2025 10-Q 31 Jul 2025
Q1 2025 $248M $23.7M -$20.9M -46.9% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025
Q4 2024 $269M $58.4M -$36.9M -38.7% 01 Oct 2024 31 Dec 2024 10-K 14 Feb 2025
Q3 2024 $306M $64.5M -$26.4M -29.1% 01 Jul 2024 30 Sep 2024 10-Q 29 Oct 2025
Q2 2024 $332M $102M +$11.9M +13.3% 01 Apr 2024 30 Jun 2024 10-Q 31 Jul 2025
Q1 2024 $320M $44.6M -$17.3M -28% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025
Q4 2023 $338M $95.3M -$23.3M -19.7% 01 Oct 2023 31 Dec 2023 10-K 14 Feb 2025
Q3 2023 $361M $90.9M -$3.7M -3.91% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024
Q2 2023 $365M $89.6M -$33.3M -27.1% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2024
Q1 2023 $398M $61.9M -$84.5M -57.7% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024
Q4 2022 $483M $119M +$766K +0.65% 01 Oct 2022 31 Dec 2022 10-K 14 Feb 2025
Q3 2022 $482M $94.6M -$62.2M -39.6% 01 Jul 2022 30 Sep 2022 10-Q 27 Oct 2023
Q2 2022 $544M $123M -$1.89M -1.52% 01 Apr 2022 30 Jun 2022 10-Q 04 Aug 2023
Q1 2022 $546M $146M +$45.5M +45.2% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023
Q4 2021 $500M $118M -$67.7M -36.5% 01 Oct 2021 31 Dec 2021 10-K 16 Feb 2024
Q3 2021 $568M $157M +$47.2M +43.1% 01 Jul 2021 30 Sep 2021 10-Q 28 Oct 2022
Q2 2021 $521M $125M +$73M +141% 01 Apr 2021 30 Jun 2021 10-Q 29 Jul 2022
Q1 2021 $448M $101M +$26.5M +35.6% 01 Jan 2021 31 Mar 2021 10-Q 29 Apr 2022
Q4 2020 $421M $186M +$126M +214% 01 Oct 2020 31 Dec 2020 10-K 17 Feb 2023
Q3 2020 $295M $110M +$52.1M +90.7% 01 Jul 2020 30 Sep 2020 10-Q 29 Oct 2021
Q2 2020 $243M $51.7M -$4.65M -8.24% 01 Apr 2020 30 Jun 2020 10-Q 30 Jul 2021
Q1 2020 $247M $74.4M +$17.8M +31.4% 01 Jan 2020 31 Mar 2020 10-Q 30 Apr 2021
Q4 2019 $230M $59.2M +$286M 01 Oct 2019 31 Dec 2019 10-K 11 Feb 2022
Q3 2019 -$56.6M $57.5M +$21.2M +58.4% 01 Jul 2019 30 Sep 2019 10-Q 30 Oct 2020
Q2 2019 -$77.8M $56.4M +$12.6M +28.8% 01 Apr 2019 30 Jun 2019 10-Q 31 Jul 2020
Q1 2019 -$90.4M $56.6M +$13M +29.7% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020
Q4 2018 -$103M -$227M -$273M -595% 01 Oct 2018 31 Dec 2018 10-K 16 Feb 2021
Q3 2018 $170M $36.3M -$2.49M -6.42% 01 Jul 2018 30 Sep 2018 10-Q 01 Nov 2019
Q2 2018 $172M $43.8M +$45.5M 01 Apr 2018 30 Jun 2018 10-Q 06 Aug 2019
Q1 2018 $127M $43.6M +$17.4M +66.5% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019
Q4 2017 $109M $45.9M +$74.1M 01 Oct 2017 31 Dec 2017 10-K 16 Apr 2018
Q3 2017 $35.1M $38.8M +$16.1M +70.8% 01 Jul 2017 30 Sep 2017 10-Q 05 Nov 2018
Q2 2017 $19M -$1.7M -$28.6M -106% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018
Q1 2017 $47.6M $26.2M +$6.01M +29.7% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018
Q4 2016 $41.6M -$28.2M -$87.7M -147% 01 Oct 2016 31 Dec 2016 10-K 16 Apr 2018
Q3 2016 $129M $22.7M -$9.97M -30.5% 01 Jul 2016 30 Sep 2016 10-K 16 Apr 2018
Q2 2016 $139M $26.9M -$13.3M -33.1% 01 Apr 2016 30 Jun 2016 10-K 16 Apr 2018
Q1 2016 $153M $20.2M -$14.1M -41.2% 01 Jan 2016 31 Mar 2016 10-K 16 Apr 2018
Q4 2015 $167M $59.5M +$8.9M +17.6% 01 Oct 2015 31 Dec 2015 10-K 16 Apr 2018
Q3 2015 $158M $32.7M -$569K -1.71% 01 Jul 2015 30 Sep 2015 10-Q 02 Nov 2016
Q2 2015 $158M $40.2M -$5.48M -12% 01 Apr 2015 30 Jun 2015 10-Q 05 Aug 2016
Q1 2015 $164M $34.3M +$13.9M +67.8% 01 Jan 2015 31 Mar 2015 10-Q 06 May 2016
Q4 2014 $150M $50.6M -$1.73M -3.31% 01 Oct 2014 31 Dec 2014 10-K 01 Mar 2017
Q3 2014 $152M $33.2M +$4.18M +14.4% 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015
Q2 2014 $148M $45.7M -$7.24M -13.7% 01 Apr 2014 30 Jun 2014 10-Q 07 Aug 2015
Q1 2014 $155M $20.5M -$14.7M -41.8% 01 Jan 2014 31 Mar 2014 10-Q 06 May 2015
Q4 2013 $169M $52.3M -$18.3M -26% 01 Oct 2013 31 Dec 2013 10-K 29 Feb 2016
Q3 2013 $188M $29.1M -$36.8M -55.9% 01 Jul 2013 30 Sep 2013 10-Q 07 Nov 2014
Q2 2013 $225M $52.9M -$20.4M -27.8% 01 Apr 2013 30 Jun 2013 10-Q 06 Aug 2014
Q1 2013 $245M $35.2M -$19.2M -35.3% 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014
Q4 2012 $264M $70.7M -$25.4M -26.4% 01 Oct 2012 31 Dec 2012 10-K 02 Mar 2015
Q3 2012 $290M $65.8M -$8.08M -10.9% 01 Jul 2012 30 Sep 2012 10-Q 12 Nov 2013
Q2 2012 $298M $73.3M +$5.12M +7.51% 01 Apr 2012 30 Jun 2012 10-Q 08 Aug 2013
Q1 2012 $292M $54.4M -$12.8M -19% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013
Q4 2011 $305M $96M +$18.2M +23.4% 01 Oct 2011 31 Dec 2011 10-K 18 Mar 2014
Q3 2011 $287M $73.9M -$880K -1.18% 01 Jul 2011 30 Sep 2011 10-Q 08 Nov 2012
Q2 2011 $288M $68.2M +$10K +0.02% 01 Apr 2011 30 Jun 2011 10-Q 09 Aug 2012
Q1 2011 $288M $67.1M +$3.87M +6.12% 01 Jan 2011 31 Mar 2011 10-Q 10 May 2012
Q4 2010 $284M $77.8M 01 Oct 2010 31 Dec 2010 10-K 18 Mar 2013
Q3 2010 $74.8M 01 Jul 2010 30 Sep 2010 10-Q 03 Nov 2011
Q2 2010 $68.2M 01 Apr 2010 30 Jun 2010 10-Q 04 Aug 2011
Q1 2010 $63.2M 01 Jan 2010 31 Mar 2010 10-Q 06 May 2011

BIO-RAD LABORATORIES, INC. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $269M -$68.8M -20.4% 01 Jan 2024 31 Dec 2024 10-K 14 Feb 2025
2023 $338M -$145M -30% 01 Jan 2023 31 Dec 2023 10-K 14 Feb 2025
2022 $483M -$17.7M -3.55% 01 Jan 2022 31 Dec 2022 10-K 14 Feb 2025
2021 $500M +$79M +18.8% 01 Jan 2021 31 Dec 2021 10-K 16 Feb 2024
2020 $421M +$192M +83.5% 01 Jan 2020 31 Dec 2020 10-K 17 Feb 2023
2019 $230M +$333M 01 Jan 2019 31 Dec 2019 10-K 11 Feb 2022
2018 -$103M -$223M -187% 01 Jan 2018 31 Dec 2018 10-K 16 Feb 2021
2017 $119M +$63.5M +114% 01 Jan 2017 31 Dec 2017 10-K 02 Mar 2020
2016 $55.7M -$111M -66.6% 01 Jan 2016 31 Dec 2016 10-K 01 Apr 2019
2015 $167M +$16.7M +11.2% 01 Jan 2015 31 Dec 2015 10-K 16 Apr 2018
2014 $150M -$19.5M -11.5% 01 Jan 2014 31 Dec 2014 10-K 01 Mar 2017
2013 $169M -$94.7M -35.9% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016
2012 $264M -$41.1M -13.5% 01 Jan 2012 31 Dec 2012 10-K 02 Mar 2015
2011 $305M +$21.2M +7.48% 01 Jan 2011 31 Dec 2011 10-K 18 Mar 2014
2010 $284M 01 Jan 2010 31 Dec 2010 10-K 18 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.